Upexi Inkomsten in het verleden
We zijn nog bezig met het verwerken van het laatste winstrapport van dit bedrijf
Verleden criteriumcontroles 0/6
Upexi's earnings have been declining at an average annual rate of -60.3%, while the Personal Products industry saw earnings growing at 11.7% annually. Revenues have been growing at an average rate of 55.4% per year.
Belangrijke informatie
-60.3%
Groei van de winst
-43.1%
Groei van de winst per aandeel
| Personal Products Groei van de industrie | 20.9% |
| Inkomstengroei | 55.4% |
| Rendement op eigen vermogen | -104.8% |
| Nettomarge | -27.3% |
| Laatste winstupdate | 31 Mar 2024 |
Recente prestatie-updates uit het verleden
Recent updates
This Analyst Just Downgraded Their Upexi, Inc. (NASDAQ:UPXI) EPS Forecasts
Feb 17
Upexi, Inc. (NASDAQ:UPXI) Doing What It Can To Lift Shares
Jun 11Grove CEO provides company update on sales and beyond
Jul 13Why Grove's (NASDAQ:GRVI) Earnings Are Weaker Than They Seem
Oct 05Grove: An Underrated CBD Player
Jul 31Opbrengsten en kosten
Hoe Upexi geld verdient en uitgeeft. Gebaseerd op laatst gerapporteerde winst, op LTM-basis.
Inkomsten en omzetgeschiedenis
| Datum | Inkomsten | Inkomsten | G+A Uitgaven | R&D-uitgaven |
|---|---|---|---|---|
| 31 Mar 24 | 84 | -23 | 33 | 0 |
| 31 Dec 23 | 91 | -20 | 35 | 0 |
| 30 Sep 23 | 97 | -14 | 37 | 0 |
| 30 Jun 23 | 81 | -15 | 36 | 0 |
| 31 Mar 23 | 66 | -2 | 29 | 0 |
| 31 Dec 22 | 49 | -1 | 25 | 0 |
| 30 Sep 22 | 30 | -7 | 24 | 0 |
| 30 Jun 22 | 23 | -6 | 20 | 0 |
| 31 Mar 22 | 24 | -1 | 18 | 0 |
| 31 Dec 21 | 26 | 0 | 15 | 0 |
| 30 Sep 21 | 25 | 3 | 11 | 0 |
| 30 Jun 21 | 24 | 3 | 9 | 0 |
| 31 Mar 21 | 16 | 0 | 7 | 0 |
| 31 Dec 20 | 11 | -3 | 8 | 0 |
| 30 Sep 20 | 9 | -5 | 8 | 0 |
| 30 Jun 20 | 7 | -5 | 7 | 0 |
| 30 Jun 19 | 2 | -1 | 2 | 0 |
Kwaliteitswinsten: UPXI is currently unprofitable.
Groeiende winstmarge: UPXI is currently unprofitable.
Analyse vrije kasstroom versus winst
Analyse van de winstgroei in het verleden
Winsttrend: UPXI is unprofitable, and losses have increased over the past 5 years at a rate of 60.3% per year.
Versnelling van de groei: Unable to compare UPXI's earnings growth over the past year to its 5-year average as it is currently unprofitable
Winst versus industrie: UPXI is unprofitable, making it difficult to compare its past year earnings growth to the Personal Products industry (22.2%).
Rendement op eigen vermogen
Hoge ROE: UPXI has a negative Return on Equity (-104.82%), as it is currently unprofitable.